Global Virology V: 21st Century Vaccines and Viruses
The purpose of this fifth volume in the Global Virology series is to describe and propose vaccines, focusing primarily on viral vaccines. In addition to human vaccines, animal viral vaccines are included since animals are used in vaccine research, and the spread of diseases to, from, and among anima...
Gorde:
| Erakunde egilea: | |
|---|---|
| Beste egile batzuk: | , , , , , |
| Formatua: | Baliabide elektronikoa eBook |
| Hizkuntza: | ingelesa |
| Argitaratua: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| Edizioa: | 1st ed. 2025. |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1007/978-3-031-77911-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-77911-4 | ||
| 003 | DE-He213 | ||
| 005 | 20260810160028.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 250712s2025 sz | o |||| 0|eng d | ||
| 020 | |a 9783031779114 |9 978-3-031-77911-4 | ||
| 024 | 7 | |a 10.1007/978-3-031-77911-4 |2 doi | |
| 050 | 4 | |a QR355-502 | |
| 072 | 7 | |a PSGL |2 bicssc | |
| 072 | 7 | |a SCI099000 |2 bisacsh | |
| 072 | 7 | |a PSG |2 thema | |
| 082 | 0 | 4 | |a 579.2 |2 23 |
| 082 | 0 | 4 | |a 616.96 |2 23 |
| 245 | 1 | 0 | |a Global Virology V: 21st Century Vaccines and Viruses |h [electronic resource] / |c edited by Paul Shapshak, Seetharaman Balaji, Pandjassarame Kangueane, Jens H. Kuhn, Charurut Somboonwit, John T. Sinnott. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2025. | |
| 300 | |a 1 online resource (XIII, 857 p. 71 illus.). |b 59 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b PDF/UA-1 |2 onix | |
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a 1-15. Individual virus vaccines (Nipah, Hendra/Nipah/Henipaviridae peptides, Circovirus, Hantavirus, Prion, Influenza, Zika, Venezuelan EEV, HIV, etc.) -- 16. Cut-across vaccines -- 17. Strategies in vaccine development and testing -- 18. Prior and anticipated barriers to vaccines -- 19. Sociological and psychiatric barriers to vaccines -- 20. International issues and barriers in vaccine development and promulgation -- 21. Clinical applications of vaccine development, promulgation, and testing -- 22. Applications of CRISPR -- 23. Applications of siRNA -- 24. Nano-molecular vaccine adjuvant technology -- 25. Vaccine development in education -- 26. The intersection of animal, avian, and insect worlds -- 27. Honeybee discrimination -- 28. Jumping genes in maize -- 29. Exclusion of gene expression. | |
| 520 | |a The purpose of this fifth volume in the Global Virology series is to describe and propose vaccines, focusing primarily on viral vaccines. In addition to human vaccines, animal viral vaccines are included since animals are used in vaccine research, and the spread of diseases to, from, and among animals, birds, and humans permeates the ecosystem. Due to climatic, geographical, and social factors, there is increased global spread of viruses and other infectious agents. Contributory factors include global warming, spread of vectors, increased human travel, encroachment into animal and avian environments, war, pestilence, malnutrition, and environmental, economic, and social collapse. GVV will address vaccines for many of the viruses addressed in previous series volumes, as well as for viruses not previously covered, and novel and future vaccine technologies. Advances in vaccine effectiveness and molecular engineering approaches are included, such as gene therapy, and CRISPR technologies. | ||
| 532 | 8 | |a Accessibility summary: This PDF has been created in accordance with the PDF/UA-1 standard to enhance accessibility, including screen reader support, described non-text content (images, graphs), bookmarks for easy navigation, keyboard-friendly links and forms and searchable, selectable text. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. Please note that a more accessible version of this eBook is available as ePub. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Virology. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Immunology. | |
| 650 | 0 | |a Internal medicine. | |
| 650 | 1 | 4 | |a Virology. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Immunology. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Internal Medicine. |
| 700 | 1 | |a Shapshak, Paul. |e editor. |0 (orcid)0000-0002-3437-3740 |1 https://orcid.org/0000-0002-3437-3740 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Balaji, Seetharaman. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Kangueane, Pandjassarame. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Kuhn, Jens H. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Somboonwit, Charurut. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Sinnott, John T. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031779107 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031779121 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031779138 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-77911-4 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 912 | |a ZDB-2-236 | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||
| 950 | |a Focus Bundle Molecular and Cellular Life Sciences (SpringerNature-85406) | ||